← All Acurx Pharmaceuticals, INC filings

Acurx Pharmaceuticals, INC 10-K annual reports

Annual reports — audited financials, the full risk-factor list, and management’s account of the year.

NASDAQ
ACXP
Acurx Pharmaceuticals, INC
10-K: Acurx Pharmaceuticals Reports 2024 Results, Highlights Ibezapolstat's Clinical Progress
Acurx Pharmaceuticals' 2024 10-K filing details the company's financial status and the advancement of its lead drug candidate, ibezapolstat, through clinical trials for Clostridioides difficile infection (CDI).
NASDAQ
ACXP
Acurx Pharmaceuticals, INC
10-K: Acurx Pharmaceuticals Details Share Structure and Corporate Governance in 10-K Filing
Acurx Pharmaceuticals' 10-K filing outlines the company's common and preferred stock structure, warrant details, and key corporate governance provisions.